271 related articles for article (PubMed ID: 17804718)
1. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
Deeb KK; Michalowska AM; Yoon CY; Krummey SM; Hoenerhoff MJ; Kavanaugh C; Li MC; Demayo FJ; Linnoila I; Deng CX; Lee EY; Medina D; Shih JH; Green JE
Cancer Res; 2007 Sep; 67(17):8065-80. PubMed ID: 17804718
[TBL] [Abstract][Full Text] [Related]
2. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
3. Initiating oncogenic event determines gene-expression patterns of human breast cancer models.
Desai KV; Xiao N; Wang W; Gangi L; Greene J; Powell JI; Dickson R; Furth P; Hunter K; Kucherlapati R; Simon R; Liu ET; Green JE
Proc Natl Acad Sci U S A; 2002 May; 99(10):6967-72. PubMed ID: 12011455
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
[TBL] [Abstract][Full Text] [Related]
5. Different gene-expression profiles for the poorly differentiated carcinoma and the highly differentiated papillary adenocarcinoma in mammary glands support distinct metabolic pathways.
Eilon T; Barash I
BMC Cancer; 2008 Sep; 8():270. PubMed ID: 18811984
[TBL] [Abstract][Full Text] [Related]
6. Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.
Hoenerhoff MJ; Shibata MA; Bode A; Green JE
Transgenic Res; 2011 Apr; 20(2):247-59. PubMed ID: 20549348
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer.
Calvo A; Perez-Stable C; Segura V; Catena R; Guruceaga E; Nguewa P; Blanco D; Parada L; Reiner T; Green JE
Prostate; 2010 May; 70(6):630-45. PubMed ID: 20058236
[TBL] [Abstract][Full Text] [Related]
8. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
[TBL] [Abstract][Full Text] [Related]
9. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of NMU-induced rat mammary tumors: cross species comparison with human breast cancer.
Chan MM; Lu X; Merchant FM; Iglehart JD; Miron PL
Carcinogenesis; 2005 Aug; 26(8):1343-53. PubMed ID: 15845649
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in the development of mammary and prostate cancer in the C3(1)/Tag transgenic mouse model.
Yoshidome K; Shibata MA; Maroulakou IG; Liu ML; Jorcyk CL; Gold LG; Welch VN; Green JE
Int J Oncol; 1998 Feb; 12(2):449-53. PubMed ID: 9458374
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
14. Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
Aprelikova O; Tomlinson CC; Hoenerhoff M; Hixon JA; Durum SK; Qiu TH; He S; Burkett S; Liu ZY; Swanson SM; Green JE
PLoS One; 2016; 11(5):e0155262. PubMed ID: 27171183
[TBL] [Abstract][Full Text] [Related]
15. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice.
Wikenheiser KA; Clark JC; Linnoila RI; Stahlman MT; Whitsett JA
Cancer Res; 1992 Oct; 52(19):5342-52. PubMed ID: 1394139
[TBL] [Abstract][Full Text] [Related]
16. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
[TBL] [Abstract][Full Text] [Related]
17. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL
Am J Pathol; 2005 Apr; 166(4):1205-16. PubMed ID: 15793299
[TBL] [Abstract][Full Text] [Related]
20. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
Kela I; Harmelin A; Waks T; Orr-Urtreger A; Domany E; Eshhar Z
Prostate; 2009 Jul; 69(10):1034-44. PubMed ID: 19343735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
